Healthequity (HQY) Price Target Increased to $70.00 by Analysts at SunTrust Banks

Healthequity (NASDAQ:HQY) had its price objective lifted by research analysts at SunTrust Banks to $70.00 in a research report issued on Tuesday, The Fly reports. The firm currently has a “buy” rating on the stock. SunTrust Banks’ target price would indicate a potential upside of 20.90% from the stock’s current price.

Several other brokerages have also issued reports on HQY. Zacks Investment Research lowered Healthequity from a “buy” rating to a “hold” rating and set a $62.00 price target on the stock. in a research note on Tuesday, February 27th. BidaskClub upgraded Healthequity from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Cantor Fitzgerald restated a “buy” rating and set a $60.00 price target on shares of Healthequity in a research note on Thursday, February 22nd. JPMorgan Chase & Co. lowered their price target on Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 24th. Finally, Robert W. Baird boosted their price target on Healthequity from $48.00 to $49.00 and gave the company a “neutral” rating in a research note on Wednesday, February 7th. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $59.29.

How to Become a New Pot Stock Millionaire

Healthequity (NASDAQ HQY) opened at $57.90 on Tuesday. Healthequity has a 12 month low of $37.62 and a 12 month high of $60.00. The stock has a market capitalization of $3,603.35, a PE ratio of 78.24, a P/E/G ratio of 2.27 and a beta of 1.46.

In other news, insider Berkley Capital, Llc sold 350,000 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $52.12, for a total value of $18,242,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Jon Kessler sold 1,332 shares of the company’s stock in a transaction that occurred on Wednesday, February 14th. The shares were sold at an average price of $55.00, for a total value of $73,260.00. Following the completion of the sale, the chief executive officer now owns 446,332 shares in the company, valued at $24,548,260. The disclosure for this sale can be found here. Over the last quarter, insiders sold 661,732 shares of company stock worth $34,493,276. Corporate insiders own 19.00% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Zions Bancorporation bought a new stake in shares of Healthequity in the 3rd quarter valued at approximately $119,000. Catalyst Capital Advisors LLC bought a new stake in Healthequity during the 4th quarter worth approximately $149,000. CIBC Asset Management Inc bought a new stake in Healthequity during the 3rd quarter worth approximately $208,000. Two Sigma Securities LLC bought a new stake in Healthequity during the 4th quarter worth approximately $208,000. Finally, Exane Derivatives grew its position in Healthequity by 78.6% during the 4th quarter. Exane Derivatives now owns 4,682 shares of the company’s stock worth $218,000 after acquiring an additional 2,060 shares during the last quarter. Institutional investors own 99.62% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3280535/healthequity-hqy-price-target-increased-to-70-00-by-analysts-at-suntrust-banks.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

The Fly

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Brokerages Expect South Jersey Industries  to Announce $0.96 Earnings Per Share
Brokerages Expect South Jersey Industries to Announce $0.96 Earnings Per Share
Analyzing AB Volvo  & Its Competitors
Analyzing AB Volvo & Its Competitors
Investors Buy High Volume of Liberty Broadband Call Options
Investors Buy High Volume of Liberty Broadband Call Options
Investors Buy High Volume of Rush Enterprises Call Options
Investors Buy High Volume of Rush Enterprises Call Options
Warrior Met Coal  and CONSOL Coal Resources  Head to Head Contrast
Warrior Met Coal and CONSOL Coal Resources Head to Head Contrast
$0.30 EPS Expected for Matador Resources  This Quarter
$0.30 EPS Expected for Matador Resources This Quarter


© 2006-2018 Ticker Report. Google+.